Pam Misajon

Pam Misajon joined Suneva in February 2017 and serves as their Vice President of Regulatory, Quality Affairs and Compliance. Ms. Misajon has over 25 years’ experience in both established and start-up medical device companies’ in the areas of regulatory, quality and clinical affairs. Her experience includes gaining U.S. and worldwide product approvals, developing compliant quality systems, and overseeing the execution of clinical studies. Prior to joining Suneva Medical, Ms. Misajon was Vice President of Regulatory Affairs for Neomend, Inc. (acquired by CR BARD in 2012) which specialized in Class III surgical sealants. Ms. Misajon has held executive positions with Ellipse Technologies, Pegasus Biologics, and Intraluminal Therapeutics.